EC Number   |
Expression |
Reference |
|---|
   3.4.24.B7 | down |
significant downregulation of expression of MMP-26, and significant 9.8fold upregulation of TGF-beta in more degenerated discs versus healthier discs |
719420 |
| 3.4.24.B7 | down |
there is significant downregulation of expression of MMP-26 in more degenerated discs vs. healthier discs |
719420 |
| 3.4.24.B7 | more |
endometrial MMP26 expression is dependent on the presence of progesterone in the early secretory phase and then gradually becomes refractory to progesterone stimulation in the late secretory phase |
733957 |
| 3.4.24.B7 | up |
preeclampsia induces a significant increase in the content and actual activity of MMP-26 in umbilical cord vein and Wharton's jelly |
753498 |
| 3.4.24.B7 | up |
regulatory effects of gonadotropin-releasing hormone I and gonadotropin-releasing hormone II, GnRH I and GnRH II, on the expression of MMP-26 in human immortalized cytotrophoblast-like cell line, B6Tert-1. The activation of JNK, but not ERK1/2, is required for GnRH I and II-stimulated MMP-26 production in B6Tert-1 cells and primary cytotrophoblasts |
713493 |
